ClinicalTrials.gg
Drug

Orlistat clinical trials

Also written Alli and Xenical.

studies test it
48
open now
6
in phase 3
3
first study started
1998

How each study uses Orlistat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Orlistat studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
23 Apr 1999 · XENICAL · NDA 020766 (FDA, Drugs@FDA)
European Union
29 Jul 1998 · Xenical · EMEA/H/C/000154 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Orlistat
31
Orlistat 120 mg
3
Orlistat 60 mg
2
Tetrahydrolipstatin
2

Brand

Alli
6
Xenical
5
Alli® 60 mg
1

Studies by the year they started

48 studies that test it; most in 2008 (6)

Studies that test Orlistat, by start year
YearStudies
19981
20022
20032
20042
20053
20071
20086
20095
20102
20111
20123
20142
20154
20161
20183
20202
20221
20231
20241
20252
20263

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
12
Phase 3
3
Phase 4
18
No phase
14

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 11 · Other 37

University of Texas Southwestern Medical Center (3) · Yale University (3) · GlaxoSmithKline (3) · Hoffmann-La Roche (2) · University of Campinas, Brazil (2) · Pennington Biomedical Research Center (2) · Khyber Medical University Peshawar (1) · Emory University (1)

Often tested with

Tested in the same studies.

Liraglutide (5) · Sibutramine (4) · Metformin (2) · Topiramate (2) · SGLT2 inhibitors (1) · DPP-4 inhibitors (1) · Behavioral Intervention (1) · Velneperit (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4

Studies that test Orlistat.

Studies

Open first, then newest update. How each study uses Orlistat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 48

See all 48 studies that test Orlistat →

Given beside what is tested · 2 — Orlistat is usual care or a partner of the new treatment
As the comparator · 6 — what is tested is compared with Orlistat

Codes

What other systems call Orlistat · ClinicalTrials.gg INT006713

  • MeSH (NLM) D000077403OrlistatConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 95M8R751W8ORLISTATConfirmed FDA, NLM, Wikidata
  • RxNorm 37925Confirmed FDA, Wikidata
  • Wikidata Q424163orlistatConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C29303OrlistatOne source FDA
  • DrugBank DB01083One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.